Recent News

• 05.21.2025 - Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference
• 05.08.2025 - Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
• 05.01.2025 - Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations
• 04.07.2025 - Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
• 03.13.2025 - Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement

Recent Filings

• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.08.2025 - EX-99.1 EX-99.1
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.08.2025 - 8-K Current report
• 05.01.2025 - 8-K Current report
• 04.23.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.23.2025 - DEF 14A Other definitive proxy statements
• 04.11.2025 - PRER14A Preliminary Proxy Soliciting materials
• 04.10.2025 - PRE 14A Other preliminary proxy statements